Current aspects of Alzheimer's disease
van Gool, W.A.; Eikelenboom, P.
Nederlands Tijdschrift Voor Geneeskunde 138(3): 116-118
1994
ISSN/ISBN: 0028-2162 PMID: 8295635 Document Number: 435935
Document emailed within 1 workday
Related Documents
Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1996: New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease Journal of Neural Transmission. Supplementum 48: 1-6
Frackowiak, R.S. 1995: Imaging and Alzheimer disease: current issues Alzheimer Disease and Associated Disorders 9(1): 5
Casey, D.A.; Robinson, K. 1990: Psychosocial aspects of Alzheimer's disease Journal of the Kentucky Medical Association 88(11): 619-623
Musiek, E.S.; Schindler, S.E. 2013: Alzheimer disease: current concepts and future directions Missouri Medicine 110(5): 395-400
Russo, C.; Venezia, V.; Salis, S.; Dolcini, V.; Schettini, G. 2002: Molecular aspects of neurodegeneration in Alzheimer's disease Functional Neurology 17(2): 65-70
Gualdi, G.F.; Colaiacomo, M.C.; Bertini, L.; Melone, A.; Rojas, M.; Di Biasi, C. 2004: Neuroimaging of Alzheimer disease: current role and future potential La Clinica Terapeutica 155(10): 429-438
Farlow, M.R. 2001: Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine Clinical Therapeutics 23(Suppl): A13-A24
Tariot, P.N. 2006: Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies Journal of Clinical Psychiatry 67(Suppl 3): 15-22; Quiz 23
Xing, M.; Ai, Y-mei.; He, R-lian.; Gao, J-wei.; Song, P-ping.; Wang, X-cheng.; Gao, C-hong.; Zhang, H-min.; Yu, H-mei. 2012: Current status and influencing factors regarding quality of life among patients with Alzheimer's disease Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 606-609
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Eleti, S. 2016: Drugs in Alzheimer's disease Dementia: An overview of current pharmacological management and future directions Psychiatria Danubina 28(Suppl-1): 136-140
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Orhan, I.Erdogan. 2012: Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease Current Medicinal Chemistry 19(14): 2252-2261